Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Search

Search Results for obesity

Statins help obese people over 40 have cardiovascular profiles similar to slim people: Study
News

Statins help obese people over 40 have cardiovascular profiles similar to slim people: Study

They will continue to face other risks associated with obesity, such as diabetes, kidney and liver diseases, and cancer

We risk sleepwalking further into an obesity epidemic: BHF
News

We risk sleepwalking further into an obesity epidemic: BHF

High levels of deprivation and easy availability of unhealthy food are driving England's obesity epidemic

Obesity on the rise in younger adults of England: Study
News

Obesity on the rise in younger adults of England: Study

Earlier onset of obesity more common among non-white groups and in deprived areas

Government, Eli Lilly join hands to make obesity treatment more accessible
News

Government, Eli Lilly join hands to make obesity treatment more accessible

The OPIP projects will use technology to provide easier ways to access obesity care - from apps and round-the clock advice on WhatsApp to AI-powered triage

UK's diabetes challenge could be helped by generic GLP-1s and biosimilars
Opinion

UK's diabetes challenge could be helped by generic GLP-1s and biosimilars

According to the World Obesity Federation, the UK is projected to have over 40 percent of adults living with obesity by 2035

Shreehas Tambe
Daily pill to prevent weight gain after stopping obesity jabs
News

Daily pill to prevent weight gain after stopping obesity jabs

Trials found that patients who took orforglipron daily for a year avoided regaining much of the weight

long working hours health risks
Obesity & Weight Management

Long working hours may be fueling the obesity crisis, scientists warn

The study found that a 1 per cent reduction in annual working hours could lead to 0.16 per cent fall in obesity rates

Obesity drugs emerge as pharma’s highest value area
News

Obesity drugs emerge as pharma’s highest value area

GLP-1 medications now drive 38 percent of projected pharma revenue, but concentration raises risk concerns